Recovery of methamphetamine associated cardiomyopathy predicted by late gadolinium enhanced cardiovascular magnetic resonance

Javier E Lopez, Khung Yeo, Gary R Caputo, Michael Buonocore, Saul Schaefer

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Methamphetamine is known to cause a cardiomyopathy which may be reversible with appropriate medical therapy and cessation of use. Late gadolinium enhancement cardiovascular magnetic resonance (CMR) has been shown to identify fibrosis in ischemic and non-ischemic cardiomyopathies. We present a case of severe methamphetamine-associated cardiomyopathy in which cardiac function recovered after 6 months. Evaluation by CMR using late gadolinium enhancement was notable for an absence of enhancement, suggesting an absence of irreversible myocyte injury and a good prognosis. CMR may be useful to predict recovery in toxin-associated non-ischemic cardiomyopathies.

Original languageEnglish (US)
Article number46
JournalJournal of Cardiovascular Magnetic Resonance
Volume11
Issue number1
DOIs
StatePublished - 2009

Fingerprint

Methamphetamine
Gadolinium
Cardiomyopathies
Magnetic Resonance Spectroscopy
Muscle Cells
Fibrosis
Wounds and Injuries
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology
  • Family Practice
  • Medicine(all)

Cite this

@article{c8bfe7dd673249118cdea42d93470d7a,
title = "Recovery of methamphetamine associated cardiomyopathy predicted by late gadolinium enhanced cardiovascular magnetic resonance",
abstract = "Methamphetamine is known to cause a cardiomyopathy which may be reversible with appropriate medical therapy and cessation of use. Late gadolinium enhancement cardiovascular magnetic resonance (CMR) has been shown to identify fibrosis in ischemic and non-ischemic cardiomyopathies. We present a case of severe methamphetamine-associated cardiomyopathy in which cardiac function recovered after 6 months. Evaluation by CMR using late gadolinium enhancement was notable for an absence of enhancement, suggesting an absence of irreversible myocyte injury and a good prognosis. CMR may be useful to predict recovery in toxin-associated non-ischemic cardiomyopathies.",
author = "Lopez, {Javier E} and Khung Yeo and Caputo, {Gary R} and Michael Buonocore and Saul Schaefer",
year = "2009",
doi = "10.1186/1532-429X-11-46",
language = "English (US)",
volume = "11",
journal = "Journal of Cardiovascular Magnetic Resonance",
issn = "1097-6647",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Recovery of methamphetamine associated cardiomyopathy predicted by late gadolinium enhanced cardiovascular magnetic resonance

AU - Lopez, Javier E

AU - Yeo, Khung

AU - Caputo, Gary R

AU - Buonocore, Michael

AU - Schaefer, Saul

PY - 2009

Y1 - 2009

N2 - Methamphetamine is known to cause a cardiomyopathy which may be reversible with appropriate medical therapy and cessation of use. Late gadolinium enhancement cardiovascular magnetic resonance (CMR) has been shown to identify fibrosis in ischemic and non-ischemic cardiomyopathies. We present a case of severe methamphetamine-associated cardiomyopathy in which cardiac function recovered after 6 months. Evaluation by CMR using late gadolinium enhancement was notable for an absence of enhancement, suggesting an absence of irreversible myocyte injury and a good prognosis. CMR may be useful to predict recovery in toxin-associated non-ischemic cardiomyopathies.

AB - Methamphetamine is known to cause a cardiomyopathy which may be reversible with appropriate medical therapy and cessation of use. Late gadolinium enhancement cardiovascular magnetic resonance (CMR) has been shown to identify fibrosis in ischemic and non-ischemic cardiomyopathies. We present a case of severe methamphetamine-associated cardiomyopathy in which cardiac function recovered after 6 months. Evaluation by CMR using late gadolinium enhancement was notable for an absence of enhancement, suggesting an absence of irreversible myocyte injury and a good prognosis. CMR may be useful to predict recovery in toxin-associated non-ischemic cardiomyopathies.

UR - http://www.scopus.com/inward/record.url?scp=74049134983&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=74049134983&partnerID=8YFLogxK

U2 - 10.1186/1532-429X-11-46

DO - 10.1186/1532-429X-11-46

M3 - Article

C2 - 19906310

AN - SCOPUS:74049134983

VL - 11

JO - Journal of Cardiovascular Magnetic Resonance

JF - Journal of Cardiovascular Magnetic Resonance

SN - 1097-6647

IS - 1

M1 - 46

ER -